Humoral response to two doses of BNT162b2 vaccination in people with HIV

Overview of SARS-CoV-2 infection in adults living with HIV

(2021) Juan Ambrosioni et al.   Lancet HIV

The BNT162b2 mRNA Vaccine Elicits Robust Humoral and Cellular Immune Responses in People Living With Human Immunodeficiency Virus (HIV)

(2021) Bezawit A Woldemeskel et al.   CLINICAL INFECTIOUS DISEASES

Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1

(2021) Itzchak Levy et al.   CLINICAL MICROBIOLOGY AND INFECTION

SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding Domain

(2021) Rafael Bayarri-Olmos et al.   JOURNAL OF IMMUNOLOGY

Antibody‐dependent neutralizing capacity of the SARS‐CoV‐2 vaccine BNT162b2 with and without previous COVID‐19 priming

(2021) Cecilie Bo Hansen et al.   JOURNAL OF INTERNAL MEDICINE

SARS-CoV-2 Antibody Responses Are Correlated to Disease Severity in COVID-19 Convalescent Individuals

(2020) Cecilie Bo Hansen et al.   JOURNAL OF IMMUNOLOGY

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

(2020) Lindsey R. Baden et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2020) Fernando P. Polack et al.   NEW ENGLAND JOURNAL OF MEDICINE

Vaccination in the adult patient infected with HIV: a review of vaccine efficacy and immunogenicity

(2019) Firas El Chaer et al.   AMERICAN JOURNAL OF MEDICINE

Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection

(2015)   NEW ENGLAND JOURNAL OF MEDICINE

Incomplete Immune Recovery in HIV Infection: Mechanisms, Relevance for Clinical Care, and Possible Solutions

(2012) Julie C. Gaardbo et al.   Clinical & Developmental Immunology